566 related articles for article (PubMed ID: 6883329)
1. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
2. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
[TBL] [Abstract][Full Text] [Related]
3. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Siemann DW; Morrissey S; Wolf K
Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
[TBL] [Abstract][Full Text] [Related]
4. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Mulcahy RT; Dembs N
Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
[TBL] [Abstract][Full Text] [Related]
5. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
6. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
Mulcahy RT
Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
8. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
9. The effect in the KHT sarcoma of CCNU and MISO on cell cycle progression evaluated by flow-cytometry.
Hill SA; Bauer KD; Keng PC; Siemann DW
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1619-22. PubMed ID: 6480450
[TBL] [Abstract][Full Text] [Related]
10. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU.
Workman P; Twentyman PR
Br J Cancer; 1982 Aug; 46(2):249-59. PubMed ID: 7150475
[TBL] [Abstract][Full Text] [Related]
11. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
[TBL] [Abstract][Full Text] [Related]
13. Increased therapeutic benefit through the addition of misonidazole to a nitrosourea-radiation combination.
Siemann DW; Hill SA
Cancer Res; 1986 Feb; 46(2):629-32. PubMed ID: 3940631
[TBL] [Abstract][Full Text] [Related]
14. Survival in subpopulations of cells derived from solid KHT sarcomas by centrifugal elutriation following treatment with CCNU and MISO.
Hill SA; Keng PC; Siemann DW
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1615-8. PubMed ID: 6480449
[TBL] [Abstract][Full Text] [Related]
15. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Hirst DG; Brown JM; Hazlehurst JL
Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
[TBL] [Abstract][Full Text] [Related]
16. Combinations of CCNU, MISO, and fractionated radiotherapy.
Siemann DW; Alliet KL
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
[TBL] [Abstract][Full Text] [Related]
17. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
[TBL] [Abstract][Full Text] [Related]
18. In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1981 Jan; 43(1):93-9. PubMed ID: 7459244
[TBL] [Abstract][Full Text] [Related]
19. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
Siemann DW
Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
Siemann DW; Alliet K; Maddison K; Wolf K
Cancer Treat Rep; 1985 Dec; 69(12):1409-14. PubMed ID: 3841024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]